- Home
- OTTR vs DYN Comparison
OTTR vs DYN Comparison
Compare OTTR & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OTTR | DYN |
|---|---|---|
| Founded | 1907 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Medicinal Chemicals and Botanical Products |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 3.4B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | OTTR | DYN |
|---|---|---|
| Price | $86.58 | $17.76 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 17 |
| Target Price | N/A | ★ $39.94 |
| AVG Volume (30 Days) | 174.0K | ★ 2.2M |
| Earning Date | 02-17-2026 | 02-26-2026 |
| Dividend Yield | ★ 2.67% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 6.62 | N/A |
| Revenue | ★ $1,299,070,000.00 | N/A |
| Revenue This Year | $0.18 | N/A |
| Revenue Next Year | $1.13 | N/A |
| P/E Ratio | $13.05 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $71.79 | $6.36 |
| 52 Week High | $90.11 | $25.00 |
Technical Indicators
Market Signals| Indicator | OTTR | DYN |
|---|---|---|
| Relative Strength Index (RSI) | 54.62 | 46.83 |
| Support Level | $85.96 | $16.00 |
| Resistance Level | $90.11 | $18.32 |
| Average True Range (ATR) | 1.89 | 0.93 |
| MACD | 0.20 | 0.07 |
| Stochastic Oscillator | 57.93 | 46.92 |
Price Performance
Historical ComparisonAbout OTTR Otter Tail Corporation
Otter Tail Corp is a U.S. energy company that operates in the electric (produces and sells electricity), manufacturing (fabricates metal components), and plastics segments (pipes for water uses). The company conducts its operations and acquires the majority of its revenue in the U.S. in the states of Minnesota, South Dakota, and North Dakota. The majority of the company's revenue is derived from the Electric segment and commercial customers, although it generates revenue from residential and industrial customers, as well.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.